Preparation of long-acting microspheres loaded with octreotide for the treatment of portal hypertensive

References

• Bhardwaj U, Sura R, Papadimitrakopoulos F, Burgess DJ. (2007). Controlling acute inflammation with fast releasing dexamethasone-PLGA microsphere/pva hydrogel composites for implantable devices. J Diabetes Sci Technol 1:8–17.
   PubMedGoogle Scholar
• Chen B, Han B, Song L, et al. (2014). A novel preparation method for octreotide acetate–loaded plga microspheres with a high drug-loading capacity and a low initial burst release, and its studies on relations between in vitro and in vivo release. Adv Polym Technol 32:1158–68.
   Web of Science ®Google Scholar
• Currow DC, Quinn S, Agar M, et al. (2015). Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction. J Pain Symptom Manage 49:814–21.
   PubMed Web of Science ®Google Scholar
• Ghassemi AH, van Steenbergen MJ, Barendregt A, et al. (2012). Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres. Pharm Res 29:110–20.
   PubMed Web of Science ®Google Scholar
• Gracia-Sancho J, Maeso-Diaz R, Fernandez-Iglesias A, et al. (2015). New cellular and molecular targets for the treatment of portal hypertension. Hepatol Int 9:183–91.
   PubMed Web of Science ®Google Scholar
• Habraken WJ, Wolke JG, Mikos AG, Jansen JA. (2006). Injectable PLGA microsphere/calcium phosphate cements: physical properties and degradation characteristics. J Biomater Sci Polym Ed 17:1057–74.
   PubMed Web of Science ®Google Scholar
• Han B, Wang HT, Liu HY, et al. (2010). Preparation of pingyangmycin PLGA microspheres and related in vitro/in vivo studies. Int J Pharm 398:130–6.
   PubMed Web of Science ®Google Scholar
• Hu Z, Liu Y, Yuan W, et al. (2011). Effect of bases with different solubility on the release behavior of risperidone loaded PLGA microspheres. Colloids Surf B Biointerfaces 86:206–11.
   PubMed Web of Science ®Google Scholar
• Ikenaga N, Liu SB, Sverdlov DY, et al. (2015). A new Mdr2(-/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer. Am J Pathol 185:325–34.
   PubMed Web of Science ®Google Scholar
• Iqbal M, Zafar N, Fessi H, Elaissari A. (2015). Double emulsion solvent evaporation techniques used for drug encapsulation. Int J Pharm 496:173–90.
   PubMed Web of Science ®Google Scholar
• Ismail NA, Gordon J, Dunning J. (2015). The use of octreotide in the treatment of chylothorax following cardiothoracic surgery. Interact Cardiovasc Thorac Surg 20:848–54.
   PubMed Web of Science ®Google Scholar
• Ito F, Fujimori H, Honnami H, et al. (2009). Study of types and mixture ratio of organic solvent used to dissolve polymers for preparation of drug-containing PLGA microspheres. Eur Polym J 45:658–67.
   Web of Science ®Google Scholar
• Kempen DH, Lu L, Kim C, et al. (2006). Controlled drug release from a novel injectable biodegradable microsphere/scaffold composite based on poly(propylene fumarate). J Biomed Mater Res A 77:103–11.
   PubMedGoogle Scholar
• Lee JS, Kim JH. (2007). The role of activated hepatic stellate cells in liver fibrosis, portal hypertension and cancer angiogenesis. Korean J Hepatol 13:309–19.
   PubMedGoogle Scholar
• Loyaga-Rendon RY, Hashim T, Tallaj JA, et al. (2015). Octreotide in the management of recurrent gastrointestinal bleed in patients supported by continuous flow left ventricular assist devices. ASAIO J 61:107–9.
   PubMed Web of Science ®Google Scholar
• Mejias M, Garcia-Pras E, Tiani C, et al. (2008). The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats. J Cell Mol Med 12:1690–9.
   PubMed Web of Science ®Google Scholar
• Mercado MA. (2015). Surgical treatment for portal hypertension. Br J Surg 102:717–8.
   PubMed Web of Science ®Google Scholar
• Pean JM, Venier-Julienne MC, Boury F, et al. (1998). NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability. J Control Release 56:175–87.
   PubMed Web of Science ®Google Scholar
• Rhee YS, Sohn M, Woo BH, et al. (2011). Sustained-release delivery of octreotide from biodegradable polymeric microspheres. AAPS PharmSciTech 12:1293–301.
   PubMed Web of Science ®Google Scholar
• Samati Y, Yüksel N, Tarimci N. (2006). Preparation and characterization of poly(D,L-lactic-co-glycolic Acid) microspheres containing flurbiprofen sodium. Drug Deliv 13:105–11.
   PubMed Web of Science ®Google Scholar
• Schouten JN, Verheij J, Seijo S. (2015). Idiopathic non-cirrhotic portal hypertension: a review. Orphanet J Rare Dis 10:67.
   PubMed Web of Science ®Google Scholar
• Szlęk J, Pacławski A, Lau R, et al. (2016). Empirical search for factors affecting mean particle size of PLGA microspheres containing macromolecular drugs. Comput Methods Programs Biomed 134:137–47.
   PubMed Web of Science ®Google Scholar
• Tripathi D, Stanley AJ, Hayes PC, et al., Clinical Services and Standards Committee of the British Society of Gastroenterology. (2015). U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 64:1680–704.
   PubMed Web of Science ®Google Scholar
• Verbeke L, Farre R, Trebicka J, et al. (2014). Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats. Hepatology 59:2286–98.
   PubMed Web of Science ®Google Scholar
• Wei G, Pettway GJ, McCauley LK, Ma PX. (2004). The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres. Biomaterials 25:345–52.
   PubMed Web of Science ®Google Scholar
• Wells M, Chande N, Adams P, et al. (2012). Meta-analysis: vasoactive medications for the management of acute variceal bleeds. Aliment Pharmacol Ther 35:1267–78.
   PubMed Web of Science ®Google Scholar
• Wu JZ, Williams GR, Li HY, et al. (2017). Insulin-loaded PLGA microspheres for glucose-responsive release. Drug Deliv 24:1513–25.
   PubMed Web of Science ®Google Scholar
• Xu Q, Chin SE, Wang CH, Pack DW. (2013). Mechanism of drug release from double-walled PDLLA(PLGA) microspheres. Biomaterials 34:3902–11.
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Takenaga M, Kitagawa A, et al. (2002). Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives. J Control Release 81:235–49.
   PubMed Web of Science ®Google Scholar
• Yang YY, Chung TS, Ng NP. (2001). Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 22:231–41.
   PubMed Web of Science ®Google Scholar
• Zhang H, Gao Y, Lv W, et al. (2011). Preparation of bleomycin A2-PLGA microspheres and related in vitro and in vivo studies. J Pharm Sci 100:2790–800.
   PubMed Web of Science ®Google Scholar
• Zhang H, Pu C, Wang Q, et al. (2018). Physicochemical characterization and pharmacokinetics of agomelatine-loaded PLGA microspheres for intramuscular injection. Pharm Res 36:9.
   PubMed Web of Science ®Google Scholar
• Zhang X, Hui Z, Wan D, et al. (2010). Alginate microsphere filled with carbon nanotube as drug carrier. Int J Biol Macromol 47:389–95.
   PubMed Web of Science ®Google Scholar
• Zhou D, Ying DJ, Xiao LY. (2000). Modified procedure for rat model of hepatocirrhosis with portal hypertension in rats. Chin J Bases Clin Gen Surg. 0022-24
   Google Scholar